25 Participants Needed

Prehabilitation for Liver Transplant Candidates

(Prehab preLT Trial)

AB
RA
OG
Overseen ByOlivia Geraci
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial will test if a program combining exercise, nutrition, and mental health support can help patients with cirrhosis become stronger and healthier before their surgery.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Prehabilitation for Liver Transplant Candidates?

Research shows that prehabilitation, which includes exercise programs before surgery, can improve physical fitness, walking distance, and quality of life for patients waiting for a liver transplant. It is considered safe and feasible, with no serious side effects reported.12345

Is prehabilitation safe for liver transplant candidates?

Prehabilitation, which includes exercise programs for liver transplant candidates, appears to be safe with no serious adverse events reported in studies. It is feasible and shows potential benefits in improving physical capacity, but larger studies are needed to confirm these findings.12678

How is prehabilitation unique for liver transplant candidates?

Prehabilitation for liver transplant candidates is unique because it focuses on improving physical fitness and overall health before surgery through a structured exercise program, which can enhance recovery and reduce surgical risks. Unlike other treatments that may focus solely on medical management, prehabilitation involves a multidisciplinary approach to optimize the patient's condition before the transplant.12489

Research Team

AB

Amine Benmassaoud, MD

Principal Investigator

Research Institute of the McGill University Health Centre

Eligibility Criteria

This trial is for adults over 18 who are on the liver transplant waiting list with diagnosed cirrhosis. They must not have severe end-stage liver disease, recent hepatic decompensation, low blood counts, significant heart issues, or conditions that limit movement or cause frequent falls.

Inclusion Criteria

I am over 18 years old.
Active on the liver transplant waiting list of the MUHC
I have been diagnosed with cirrhosis.

Exclusion Criteria

Biological Model for End Stage Liver Disease >20
My liver has not failed in the last month.
I have had multiple large fluid removals from my abdomen.
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Prehabilitation

Participants undergo a multimodal prehabilitation program combining exercise training, nutritional optimization, and psychological support

24 weeks
Regular visits for supervised exercise and assessments

Follow-up

Participants are monitored for safety and effectiveness after the prehabilitation program

12 months

Treatment Details

Interventions

  • Prehabilitation
Trial OverviewThe study tests a prehabilitation program for those awaiting liver transplants. It includes exercise training, nutritional support and psychological care to see if it's doable, safe and effective in improving patient outcomes before surgery.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: PrehabilitationExperimental Treatment1 Intervention
Multimodal prehabilitation program

Prehabilitation is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Prehabilitation for:
  • Preparation for liver transplantation in patients with cirrhosis
🇺🇸
Approved in United States as Prehabilitation for:
  • Preparation for liver transplantation in patients with cirrhosis
🇨🇦
Approved in Canada as Prehabilitation for:
  • Preparation for liver transplantation in patients with cirrhosis

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

Trials
476
Recruited
170,000+

Canadian Donation and Transplantation Research Program

Collaborator

Trials
2
Recruited
40+

Canadian Association for the Study of the Liver

Collaborator

Trials
1
Recruited
30+

Findings from Research

Prehabilitation programs for patients awaiting orthotopic liver transplantation (OLT) significantly improve physical fitness measures such as VO2 peak, walking distance, and hand grip strength, indicating enhanced aerobic capacity and quality of life.
The review included 1,094 patients and found that prehabilitation is generally safe, with no serious adverse events reported, although adherence rates varied and larger trials are needed to confirm these findings.
Physical Effects, Safety and Feasibility of Prehabilitation in Patients Awaiting Orthotopic Liver Transplantation, a Systematic Review.Jetten, WD., Hogenbirk, RNM., Van Meeteren, NLU., et al.[2022]
A 6-week supervised exercise program for patients with cirrhotic liver disease awaiting liver transplantation was feasible, with 56% of participants completing it, indicating that such prehabilitation can be implemented effectively.
Participants in the exercise group showed a significant improvement in peak oxygen consumption (VO2peak), increasing from 16.2 to 18.5 mL/kg/min, while the control group experienced a decline, suggesting that exercise can enhance cardiopulmonary fitness before major surgery.
An Outpatient Hospital-based Exercise Training Program for Patients With Cirrhotic Liver Disease Awaiting Transplantation: A Feasibility Trial.Morkane, CM., Kearney, O., Bruce, DA., et al.[2021]
A prehabilitation program (PP) for patients undergoing elective liver resection significantly reduced overall postoperative morbidity from 52.9% to 30%, indicating improved safety and recovery outcomes.
Patients in the PP group also experienced enhanced quality of life and a trend towards cost savings, with a 16.5% reduction in median costs, suggesting that preoperative optimization can be both effective and economically beneficial.
Prehabilitation Program Improves Outcomes of Patients Undergoing Elective Liver Resection.Wang, B., Shelat, VG., Chow, JJL., et al.[2020]

References

Physical Effects, Safety and Feasibility of Prehabilitation in Patients Awaiting Orthotopic Liver Transplantation, a Systematic Review. [2022]
An Outpatient Hospital-based Exercise Training Program for Patients With Cirrhotic Liver Disease Awaiting Transplantation: A Feasibility Trial. [2021]
Prehabilitation Program Improves Outcomes of Patients Undergoing Elective Liver Resection. [2020]
Quality of Life and Functional Mobility After Progressive Resistance Exercise in an Adolescent With a Liver Transplant. [2021]
Intensive Early Rehabilitation in the Intensive Care Unit for Liver Transplant Recipients: A Randomized Controlled Trial. [2018]
Home-Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study. [2021]
Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. [2019]
The role of prehabilitation on short-term outcomes after liver transplantation: A review of the literature and expert panel recommendations. [2023]
Randomized clinical trial of prehabilitation in colorectal surgery. [2022]